Skip to main content

Redefining Test Strips: Test Strip Market Set to Soar Past USD 12.64 Billion by 2030

The global Test Strip market size is expected to reach USD 12.64 billion by 2030 and exhibit a CAGR of 9.5% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases, favorable reimbursement policies, growing adoption of self-monitoring devices, strategic collaborations and partnerships among manufacturers and healthcare providers are fueling the market’s growth.

Westford, USA, July 10, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the test strip market, increasing adoption of digital test strip solutions, development of smartphone-compatible test strips and apps, integration of artificial intelligence and machine learning in test strip technology, growing demand for personalized and at-home testing, rising focus on continuous glucose monitoring, expanding applications beyond glucose testing (e.g., pregnancy tests, infectious disease testing), emphasis on user-friendly and intuitive test strip designs, advancements in connectivity and data management capabilities, are the trends that aid in the market’s growth.

Browse in-depth TOC on “Test Strip Market”

  • Pages – 250
  • Tables – 90
  • Figures – 76

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/test-strip-market

Test strips are small, disposable strips that are used to measure the concentration of a specific substance in a sample. They are often used in medical testing, such as to measure blood glucose or cholesterol levels.

Prominent Players in Test Strip Market

  • Abbott
  • Bayer
  • Bio-Rad Laboratories
  • DiaSorin
  • Dynacare
  • Esterline Technologies
  • Fujifilm
  • Genzyme
  • Grifols
  • Hologic
  • Immunodiagnostic Systems
  • Johnson & Johnson
  • LifeScan
  • Nova Biomedical
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Trinity Biotech
  • Uni-Med
  • Wako Chemicals

Glucose Test Strip Demand to Grow Substantially in the Forecast Period

Glucose test strips dominated the global market owing to the rising prevalence of diabetes. It is also an essential tool for diabetes management. People with diabetes must monitor their blood glucose levels to adjust their medication, diet, and lifestyle accordingly. This ongoing need for monitoring ensures a consistent demand for glucose test strips.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/test-strip-market

Diabetes Management is the Leading Application Segment

In terms of application, diabetes management is the leading segment due to the prevalence of diabetes. In addition, individuals with diabetes need to monitor their blood glucose levels regularly to manage their condition effectively. Test strips play a crucial role in this process by providing a quick and convenient method for measuring blood glucose levels at home or on-the-go.

North America is the leading Market Due to the High Prevalence of Chronic Diseases

Region-wise, North America is one of the largest growing markets with a huge emphasis on chronic disease. The region has a well-developed healthcare infrastructure, including hospitals, clinics, and diagnostic centers. This infrastructure supports the accessibility and availability of test strips, ensuring their widespread use and distribution.

A recent report thoroughly analyzes the major players operating within the Test Strip market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavors to develop innovative solutions that cater to the ever-increasing demand for Test Strip.

Key Developments in Test Strip Market

  • In late 2022 Abbot acquired the Medica Corporation

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/test-strip-market

Key Questions Answered in Test Strip Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Osteoarthritis Treatment Market

Global Reprocessed Medical Devices Market

Global Molecular Diagnostics Market

Global Cardiac Pacemaker Market

Global History and Cytology Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.